Coronavirus (COVID-19)
News and updates on the novel coronavirus, COVID-19.
-
Promising interim data testing the efficacy of a monoclonal antibody cocktail developed to prevent SARS-CoV-2 infection has been announced, but there are concerns the prohibitive cost of producing the therapy will limit widespread use.
-
Eli Lilly has announced its antibody treatment can reduce a person’s risk of contracting COVID-19 by up to 80 percent. These preliminary results suggest the treatment may be an effective way to rapidly suppress outbreaks in unvaccinated communities.
-
A new study projects the COVID-19 pandemic to generate the largest single-year decline in US life expectancy in at least 40 years. The declines are especially prominent in minority communities, and are expected to continue over the coming years.
-
A new study has affirmed men seem much more vulnerable to COVID-19 than women. The study found men, independent of age, are more likely to contract the virus, suffer from severe complications, and die from the disease compared to women.
-
Gaming brand Razer looks to the future of face masks with its Project Hazel, a reusable transparent mask concept with detachable filters, a built-in mic and amplifier, and Chroma RGB LED lights for those keen on embracing some cyberpunk techno flair.
-
A robust new study has comprehensively demonstrated how SARS-CoV-2, the coronavirus that causes COVID-19, can infect the brain and central nervous system. The study validates a growing body of research attributing neurological issues to COVID-19.
-
Early findings from a clinical trial suggest severely ill COVID-19 patients do not benefit from a therapy involving infusions of plasma from those recovered from the disease. The trial continues to investigate the therapy in moderately ill patients.
-
A first-of-its-kind study has found a link between COVID-19 severity and the gut microbiome. The research suggests specific microbial patterns correlate with disease severity and those bacterial imbalances may account for some cases of “long COVID”.
-
In the largest and longest follow-up study to date investigating the lingering effects of COVID-19, researchers have found more than two-thirds of hospitalized patients report at least one ongoing symptom six months after contracting the disease.
-
Health authorities in the UK have recommended extending dosing schedules for COVID-19 vaccines, claiming one dose offers short-term protection despite trials only testing two-dose regimes. US authorities call the change risky and unproven.
-
Stefano Boeri Architetti is perhaps best known for its greenery covered buildings. However, the Italian firm is now turning its hand to the COVID-19 virus fight with a solar-powered building that will be used to administer vaccinations.
-
A rapid COVID-19 test promises accurate results in under 30 minutes using a simple hand-held device, a nasal swab and a smartphone camera. The technology can also be modified to detect other viral diseases.